Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07318402

Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study

This is a multicenter, single-arm, prospective, observational study designed to evaluate bronchoscopist radiation exposure during standard-of-care image-guided robotic-assisted bronchoscopy (RAB) for sampling of a single pulmonary parenchymal lesion.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Orlando Health (Data Collection Only), Orlando, Florida, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Operator performing image-guided RAB on adult patients (age ≥18 years old)
  • A single participating operator per study site
  • Image-guided RAB procedure is planned for standard of care diagnostic sampling of a single parenchymal lung lesion at participating sites

Exclusion criteria

  • Operator refusal to participate
  • Image-guided RAB procedure performed on:
  • Patients age <18 years old
  • Pregnant women
  • Patients undergoing standard of care robotic assisted bronchoscopy with plan to sample >1 pulmonary parenchymal lesion
  • Patients undergoing standard of care robotic assisted bronchoscopy for lesion localization (injection of dye/marker or fiducial marker deployment)
  • Patients undergoing standard of care robotic assisted bronchoscopy for a therapeutic intervention

Treatment and study plan

Primary outcomes

  1. total operator radiation exposure dose

    Time frame: 1 year

    as captured by a radiation dosimetry badge over 50 consecutive procedures. All study procedures in which image-guided RAB was performed for the sampling of a single parenchymal lung lesion will be evaluable for the primary endpoint.

Study contacts

Contact information is provided by the study sponsor or research team.

Catherine Oberg

CONTACT

212-639-2773

Or Kalchiem-Dekel, MD

CONTACT

[email protected]

212-639-5061

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Registry information

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Jan 6, 2026
Registry last updated
Jul 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.